325 related articles for article (PubMed ID: 36164570)
21. Nine-gene pharmacogenomics profile service: The Mayo Clinic experience.
Matey ET; Ragan AK; Oyen LJ; Vitek CR; Aoudia SL; Ragab AK; Fee-Schroeder KC; Black JL; Moyer AM; Nicholson WT; Shrestha S; McAllister TM; Sinnwell JP; Faubion SS; Lazaridis KN
Pharmacogenomics J; 2022 Feb; 22(1):69-74. PubMed ID: 34671112
[TBL] [Abstract][Full Text] [Related]
22. Genetic Variation among Pharmacogenes in the Sardinian Population.
Idda ML; Zoledziewska M; Urru SAM; McInnes G; Bilotta A; Nuvoli V; Lodde V; Orrù S; Schlessinger D; Cucca F; Floris M
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077453
[TBL] [Abstract][Full Text] [Related]
23. Comparison of targeted vs. expanded pharmacogenomic testing: What are we missing?
Chambal M; Forsthoffer C; Egnaczyk A; Seitz M; Grande K; Ashcraft K; Wick JA; Blaxall BC
J Am Pharm Assoc (2003); 2023; 63(3):939-945. PubMed ID: 37024375
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of pharmacogenomic evidence for drugs related to
Reeves AA; Hopefl R; Deb S
Drug Metab Pers Ther; 2023 Mar; 38(1):65-78. PubMed ID: 36257916
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of population-level pharmacogenetic actionability in Alabama.
Davis BH; Williams K; Absher D; Korf B; Limdi NA
Clin Transl Sci; 2021 Nov; 14(6):2327-2338. PubMed ID: 34121327
[TBL] [Abstract][Full Text] [Related]
26. Pharmacogenomic information from CPIC and DPWG guidelines and its application on drug labels.
Yoon DY; Lee S; Ban MS; Jang IJ; Lee S
Transl Clin Pharmacol; 2020 Dec; 28(4):189-198. PubMed ID: 33425802
[TBL] [Abstract][Full Text] [Related]
27. Pharmacogenomic allele coverage of genome-wide genotyping arrays: a comparative analysis.
Lenz C; Narang A; Bousman CA
Pharmacogenet Genomics; 2024 Jun; 34(4):130-134. PubMed ID: 38359167
[TBL] [Abstract][Full Text] [Related]
28. Identification of pharmacogenetic variants from large scale next generation sequencing data in the Saudi population.
Goljan E; Abouelhoda M; ElKalioby MM; Jabaan A; Alghithi N; Meyer BF; Monies D
PLoS One; 2022; 17(1):e0263137. PubMed ID: 35089958
[TBL] [Abstract][Full Text] [Related]
29. Identification of high-impact gene-drug pairs for pharmacogenetic testing in Alberta, Canada.
Fan M; Yarema MC; Box A; Hume S; Aitchison KJ; Bousman CA
Pharmacogenet Genomics; 2021 Feb; 31(2):29-39. PubMed ID: 32826605
[TBL] [Abstract][Full Text] [Related]
30. Pharmacogenetic profiling via genome sequencing in children with medical complexity.
Pan A; Scodellaro S; Khan T; Ushcatz I; Wu W; Curtis M; Cohen E; Cohn RD; Hayeems RZ; Meyn MS; Orkin J; Otal J; Reuter MS; Walker S; Scherer SW; Marshall CR; Cohn I; Costain G
Pediatr Res; 2023 Mar; 93(4):905-910. PubMed ID: 36167815
[TBL] [Abstract][Full Text] [Related]
31. Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics.
Naranjo MG; Rodrigues-Soares F; Peñas-Lledó EM; Tarazona-Santos E; Fariñas H; Rodeiro I; Terán E; Grazina M; Moya GE; López-López M; Sarmiento AP; Calzadilla LR; Ramírez-Roa R; Ortiz-López R; Estévez-Carrizo FE; Sosa-Macías M; Barrantes R; LLerena A;
OMICS; 2018 Sep; 22(9):575-588. PubMed ID: 30183544
[TBL] [Abstract][Full Text] [Related]
32. Characterization of pharmacogenomic variants in a Brazilian admixed cohort of elderly individuals based on whole-genome sequencing data.
Bertholim-Nasciben L; Scliar MO; Debortoli G; Thiruvahindrapuram B; Scherer SW; Duarte YAO; Zatz M; Suarez-Kurtz G; Parra EJ; Naslavsky MS
Front Pharmacol; 2023; 14():1178715. PubMed ID: 37234706
[No Abstract] [Full Text] [Related]
33. Population genetic polymorphisms of pharmacogenes in Zimbabwe, a potential guide for the safe and efficacious use of medicines in people of African ancestry.
Mbavha BT; Kanji CR; Stadler N; Stingl J; Stanglmair A; Scholl C; Wekwete W; Masimirembwa C
Pharmacogenet Genomics; 2022 Jul; 32(5):173-182. PubMed ID: 35190514
[TBL] [Abstract][Full Text] [Related]
34. Frequencies of pharmacogenomic alleles across biogeographic groups in a large-scale biobank.
Li B; Sangkuhl K; Whaley R; Woon M; Keat K; Whirl-Carrillo M; Ritchie MD; Klein TE
Am J Hum Genet; 2023 Oct; 110(10):1628-1647. PubMed ID: 37757824
[TBL] [Abstract][Full Text] [Related]
35. Added Value of Clinical Sequencing: WGS-Based Profiling of Pharmacogenes.
Caspar SM; Schneider T; Meienberg J; Matyas G
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32225115
[TBL] [Abstract][Full Text] [Related]
36. Drug Use among Nursing Home Residents in Denmark for Drugs Having Pharmacogenomics Based (PGx) Dosing Guidelines: Potential for Preemptive PGx Testing.
Vermehren C; Søgaard Nielsen R; Jørgensen S; Drastrup AM; Westergaard N
J Pers Med; 2020 Jul; 10(3):. PubMed ID: 32752034
[TBL] [Abstract][Full Text] [Related]
37. Clinical Application of Pharmacogenetics: Where are We Now?
van Schaik RH;
EJIFCC; 2013 Feb; 24(3):105-12. PubMed ID: 27683445
[TBL] [Abstract][Full Text] [Related]
38. Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Switzerland: A Descriptive Study Using the Helsana Database.
Wittwer NL; Meier CR; Huber CA; Meyer Zu Schwabedissen HE; Allemann S; Schneider C
Pharmgenomics Pers Med; 2022; 15():967-976. PubMed ID: 36447837
[TBL] [Abstract][Full Text] [Related]
39. Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?-Results from the ADRED Study.
Just KS; Dormann H; Schurig M; Böhme M; Fracowiak J; Steffens M; Scholl C; Seufferlein T; Gräff I; Schwab M; Stingl JC
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32527038
[TBL] [Abstract][Full Text] [Related]
40. A Narrative Review on Pharmacogenomics in Psychiatry: Scientific Definitions, Principles, and Practical Resources.
Palumbo S; Mariotti V; Pellegrini S
J Clin Psychopharmacol; 2024 Jan-Feb 01; 44(1):49-56. PubMed ID: 38100778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
